753545
Last Update Posted: 2025-02-03
Recruiting has ended
Females accepted | 18 Years-130 Years |
265 Estimated Participants | Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
The primary purpose of this study to determine if AZD2281 is effective and well tolerated in maintaining the improvement in your cancer after previous platinum-based chemotherapy
Eligibility
Relevant conditions:
Ovarian Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov